Login to Your Account



Breast-Case Scenario: Kadcyla Price Set at Premium to Others

By Randy Osborne
Staff Writer

Monday, February 25, 2013
The FDA's approval Thursday of T-DM1 surprised few, though the price tag, box warnings and brand name Kadcyla may have raised some eyebrows.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription